Q4 FY2026
Revenue & Profit in ₹ Crores
| Quarter | Revenue | Net Profit | OPM | EPS |
|---|---|---|---|---|
| Q4 2026 | ₹1,003.4 | ₹79.7 | 12.1% | ₹3.30 |
| Q3 2026 | ₹942.1 | ₹102.9 | 12.7% | ₹4.26 |
| Q1 2026 | ₹760.8 | ₹116.4 | 17.6% | ₹4.82 |
| Q4 2025 | ₹755.6 | ₹117.6 | 16.8% | ₹4.88 |
| Q3 2025 | ₹720.4 | ₹109.7 | 15.5% | ₹4.55 |
Revenue & Profit in ₹ Crores (Yearly)
| Year | Revenue | Net Profit | EBITDA | OPM |
|---|---|---|---|---|
| FY 2026 | ₹3,510.5 | ₹401.1 | ₹670.8 | 14.0% |
| FY 2025 | ₹2,839.3 | ₹406.7 | ₹641.5 | 16.0% |
| FY 2024 | ₹2,589.6 | ₹336.7 | ₹581 | 16.8% |
| FY 2023 | ₹2,306.1 | ₹266.1 | ₹454.1 | 14.6% |
Top companies in the same sector by market cap
| Company | Mkt Cap | P/E | ROCE | ROE | D/E | OPM |
|---|---|---|---|---|---|---|
| INDGN ★ | ₹12,569 Cr | 31.45 | 13.94% | 13.94% | 0.05x | 12.14% |
| SUNPHARMA | ₹4,27,609 Cr | 37.32 | 15.73% | 14.72% | 0.06x | 18.90% |
| MAXHEALTH | ₹95,110 Cr | 66.21 | 11.94% | 14.33% | 0.32x | 22.56% |
| AUROPHARMA | ₹90,029 Cr | 25.94 | 12.55% | 9.93% | 0.21x | 15.11% |
| ABBOTINDIA | ₹57,724 Cr | 36.63 | 36.14% | 34.46% | 0.04x | 27.01% |
| AJANTPHARM | ₹41,836 Cr | 39.55 | 27.99% | 25.39% | 0.06x | 51.40% |
All values in ₹ Crores
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Total Assets | ₹3,325.9 | ₹2,545.6 | ₹2,203.87 | ₹1,353.47 |
| Equity | ₹2,615.6 | ₹1,429.1 | ₹1,063.72 | ₹763.9 |
| Total Debt | ₹101.6 | ₹489.6 | ₹502.58 | ₹65.75 |
| Cash | ₹241 | ₹188.6 | ₹73.58 | ₹506.28 |
| Net Debt | — | ₹214.5 | ₹320.75 | — |
| Working Capital | ₹1,965.5 | ₹1,179.9 | ₹959.56 | ₹689.59 |
Q1 FY2027
No recent corporate actions
50 mutual fund schemes
Ask: "Is Indegene Ltd stock a good buy right now?" — Get RSI, MACD, ROCE + AI recommendation
Analyse with OrionGet free stock analysis, market insights, and investment ideas delivered to your inbox.
No spam. Unsubscribe anytime.
Indegene Ltd is listed on the NSE under the Healthcare sector, Healthcare Research Analytics & Technology industry. ISIN: INE065X01017. Track live share price, technical analysis, RSI, MACD, PE ratio, and smart money holdings on VestAI — India's AI-powered stock analysis platform.